Table 3.
Author | Year | Method | Deposition | Surfactant | Breathing | Ventilation mode | Animal |
---|---|---|---|---|---|---|---|
Lewis et al.26 | 1991 | Nebulization | 2.7% | Survanta | Intubated | IPPV | Lamb |
Lewis et al.27 | 1991 | Nebulization | 3.6% | Survanta | Intubated | IPPV | Rabbit |
Lewis et al.28 | 1993 | Nebulization | 6.1% | Survanta | Intubated | IPPV | Sheep |
Dijk et al.18 | 1997 | Nebulization | 8.4% | Alveofact | Intubated | IPPV | Rabbit |
Dijk et al.6 | 1998 | Nebulization | 9.8% | Alveofact | Intubated | HFV | Rabbit |
Fok et al.29 | 1998 | Nebulization | 0.1–1% | Survanta/Exosurf | Intubated | IPPV | Rabbit |
Wagner et al.21 | 2000 | Atomization | 86.5% | Poractant alfa | Intubated | IPPV | Rabbit |
Rahmel et al.20 | 2012 | Aerosolized | 1% | rSP-C | Spontaneous | nCPAP | Lamb |
Rey-Santano et al.30 | 2013 | Aerosolized | Not reported | Poractant alfa | Intubated | IPPV | Lamb |
Linnér et al.14 | 2015 | Nebulization | 14% | Poractant alfa | Spontaneous | nCPAP | Pig |
Milesi et al.16 | 2016 | Atomization | Not reported | Poractant alfa | Intubated | IPPV | Lamb |
Hutten et al. 31 | 2015 | Nebulization | Not significant | Poractant alfa | Spontaneous | nCPAP | Lamb |
Milesi et al.22 | 2017 | Atomization | 32% | Poractant alfa | Spontaneous | nCPAP | Lamb |
Gregory et al. 32 | 2019 | Nebulization | 11.4% | Lucinactant | Spontaneous | nCPAP | Macaque |